Howard J Leonhardt - Net Worth and Insider Trading

Howard J Leonhardt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Howard J Leonhardt owns 1 companies in total, including US Stem Cell Inc (USRM) .

Click here to see the complete history of Howard J Leonhardt’s form 4 insider trades.

Insider Ownership Summary of Howard J Leonhardt

Ticker Comapny Transaction Date Type of Owner
USRM US Stem Cell Inc 2007-10-02 director & 10 percent owner & Executive Chairman & CTO

Howard J Leonhardt Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Howard J Leonhardt Ownership Network

Ownership Network List of Howard J Leonhardt

No Data

Ownership Network Relation of Howard J Leonhardt

Insider Network Chart

Howard J Leonhardt Owned Company Details

What does US Stem Cell Inc do?

Who are the key executives at US Stem Cell Inc?

Howard J Leonhardt is the director & 10 percent owner & Executive Chairman & CTO of US Stem Cell Inc. Other key executives at US Stem Cell Inc include Chief Science Officer Kristin C Comella , Vice President,Sales&Marketing Matthew J Fendrich , and VP of Financial Operations Nicholas M Burke .

US Stem Cell Inc (USRM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of US Stem Cell Inc (USRM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of US Stem Cell Inc (USRM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

US Stem Cell Inc (USRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

US Stem Cell Inc Insider Transactions

No Available Data

Howard J Leonhardt Mailing Address

Above is the net worth, insider trading, and ownership report for Howard J Leonhardt. You might contact Howard J Leonhardt via mailing address: 13794 Nw 4th Street, Suite 212, Sunrise Fl 33325.

Discussions on Howard J Leonhardt

No discussions yet.